home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GlycoMimetics, Inc. - Common Stock (NQ:GLYC)

0.1570 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 13, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GlycoMimetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session ↗

November 11, 2022

Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program.

Via Benzinga

GlycoMimetics Reports Highlights and Financial Results for Third Quarter 2022

November 09, 2022

From GlycoMimetics, Inc.

Via Business Wire

Recap: GlycoMimetics Q2 Earnings ↗

August 03, 2022

GlycoMimetics (NASDAQ:GLYC) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: GlycoMimetics Q1 Earnings ↗

April 28, 2022

GlycoMimetics (NASDAQ:GLYC) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: GlycoMimetics Q4 Earnings ↗

March 03, 2022

GlycoMimetics (NASDAQ:GLYC) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday ↗

November 10, 2022

Gainers

Via Benzinga

GlycoMimetics to Participate in Two Upcoming Investor Conferences

November 08, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics Announces New Uproleselan Clinical Data in Both Frontline Unfit and Treated Secondary Acute Myeloid Leukemia Will Be Presented at ASH Annual Meeting

November 03, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics to Report Third Quarter Financial Results on November 9, 2022

November 02, 2022

From GlycoMimetics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 20, 2022

Gainers Nuwellis (NASDAQ:NUWE) stock rose 13.9% to $0.28 during Thursday's after-market session. The company's market cap stands at $8.9 million.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 20, 2022

Gainers CinCor Pharma (NASDAQ:CINC) shares moved upwards by 19.5% to $33.0 during Tuesday's after-market session. The market value of their outstanding shares is at $1.4 billion.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 20, 2022

Via Benzinga

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

September 09, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics to Participate in Upcoming H.C. Wainwright 24th Annual Global Investment Conference

September 07, 2022

From GlycoMimetics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 06, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

September 06, 2022

Good morning, trader! It's time to start off the day with a breakdown of the biggest pre-market stock movers for Tuesday morning!

Via InvestorPlace

GlycoMimetics Appoints Edwin Rock, M.D., Ph.D. as Chief Medical Officer

September 06, 2022

From GlycoMimetics, Inc.

Via Business Wire

Why DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving Premarket ↗

September 06, 2022

Gainers First Wave BioPharma, Inc. (NASDAQ: FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 15, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 11, 2022

Via Benzinga

GlycoMimetics Reports Highlights and Financial Results for Second Quarter 2022

August 03, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics to Report Second Quarter Financial Results on August 3, 2022

July 27, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics to Participate at Upcoming Jefferies 2022 Healthcare Conference

June 02, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics Reports Highlights and Financial Results for First Quarter 2022

April 28, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗

April 26, 2022

GlycoMimetics (NASDAQ:GLYC) will host a conference call at 08:30 AM ET on April 28, 2022, to discuss Q1 2022 earnings results. How to Attend GlycoMimetics (GLYC) Conference Call Follow this link to...

Via Benzinga

GlycoMimetics to Report First Quarter Financial Results on April 28, 2022

April 25, 2022

From GlycoMimetics, Inc.

Via Business Wire

GlycoMimetics's Return On Capital Employed Insights ↗

March 09, 2022

GlycoMimetics (NASDAQ:GLYC) brought in sales totaling $18.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 0.52%, resulting in a loss...

Via Benzinga

63 Biggest Movers From Yesterday ↗

March 04, 2022

Gainers Indonesia Energy Corporation Limited (NASDAQ: INDO) shares climbed 39.3% to close at $20.20 on Thursday after jumping around 35% on Wednesday. DBV Technologies S.A. (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 03, 2022

Gainers Tonix Pharmaceuticals (NASDAQ:TNXP) stock rose 49.1% to $0.28 during Thursday's regular session. As of 12:31 EST, Tonix Pharmaceuticals's stock is trading...

Via Benzinga

Earnings Scheduled For March 3, 2022 ↗

March 03, 2022

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com